Apoquel (Oclacitinib) for Dogs: The Complete UK Guide to This Anti Itch Medication

What is Apoquel (Oclacitinib) and What is It Used For?

Apoquel is the brand name for oclacitinib maleate, an oral anti itch medication for dogs manufactured by Zoetis. It was the first Janus kinase (JAK) inhibitor licensed for veterinary use and is classified as a POM-V (Prescription Only Medicine Veterinarian) in the UK, meaning it requires a valid veterinary prescription.

It is licensed for the treatment of pruritus (itching) associated with allergic skin disease in dogs over 12 months of age. Clinical indications include:

• Canine atopic dermatitis (CAD) chronic, genetically predisposed inflammatory skin disease
• Allergic skin reactions  including environmental allergen hypersensitivity
• Flea allergy dermatitis (FAD) where itching persists despite flea control
• Food allergy-associated pruritus as a symptomatic measure while dietary investigations are conducted

Apoquel is not licensed for use in dogs under 12 months of age or in breeding, pregnant, or lactating females. It is not licensed for use in cats in the UK.

💡 Clinical fact: Apoquel does not treat the underlying cause of allergic skin disease — it controls the symptoms. A dog whose itch is well-controlled on Apoquel still has atopic dermatitis. This is why identifying and managing triggers alongside medication produces better long-term outcomes than medication alone.

How Does Apoquel Work? The JAK Inhibitor Mechanism Explained

In dogs with atopic dermatitis, the immune system overreacts to environmental allergens — pollen, dust mites, mould, grass. This triggers a cascade of inflammatory signalling involving cytokines including IL-31, IL-4, IL-13, and IL-2. IL-31 is the primary driver of itch: it binds to receptors on nerve fibres in the skin and transmits the itch signal directly to the brain. The more IL-31 is produced, the more intensely the dog itches.

These cytokines signal through intracellular enzymes called Janus kinases (JAKs). Apoquel inhibits JAK1 and JAK3 specifically, blocking the signalling that converts allergen exposure into itch and inflammation. The result is that the cytokine cascade is interrupted before itch signals are generated.

This is fundamentally different from steroids, which suppress the entire immune response broadly, and from antihistamines like Piriton, which only block histamine receptors. Histamine is not the primary driver of itch in atopic dermatitis which is why antihistamines are largely ineffective for most chronically itchy dogs.

Apoquel begins working within 4 hours of the first dose. Full effect is typically seen within 24 hours one of its main clinical advantages over cyclosporine (Atopica), which takes 4–6 weeks to reach full effect.

💡 Clinical fact: IL-31 is the primary driver of itch in canine atopic dermatitis — and histamine is not. This is why Piriton and other antihistamines are largely ineffective for most itchy dogs, while Apoquel and Cytopoint (which both target IL-31-related pathways) are significantly more effective.

Full Side Effect and Adverse Event Profile

The following data comes directly from the UK VMD Summary of Product Characteristics for Apoquel and post-marketing surveillance data. This is the complete picture.

Apoquel (oclacitinib) is a prescription-only oral anti itch medication for dogs, widely used across the UK to treat pruritus (itching) and skin inflammation caused by atopic dermatitis, flea allergy dermatitis, and other allergic skin conditions. It works by inhibiting Janus kinase (JAK) enzymes specifically JAK1 and JAK3  that drive the cytokine cascade responsible for itch in allergic dogs, with itch relief beginning within 4 hours of the first dose. This is the complete UK guide to Apoquel: how it works, the full side effect and adverse event profile from official UK VMD regulatory data, a blood monitoring guide for long-term use, a cost breakdown with prescription savings advice, a head-to-head comparison with Cytopoint, what to do if Apoquel stops working, and evidence-based alternatives. Written and reviewed by a UK-registered clinical pharmacist.

💡 Clinical fact: Pyoderma (bacterial skin infection) is listed as a very common adverse event with Apoquel occurring in more than 1 in 10 treated dogs. Skin lumps and papillomas are also in this category. This doesn't make Apoquel unsuitable, but it means regular vet monitoring is not optional it is clinically essential.

Common side effects:

• Vomiting
• Diarrhoea
• Decreased appetite
• Lethargy
• Skin infections, dogs on Apoquel are more prone to secondary bacterial and fungal infections, particularly with prolonged use

Serious risks with long-term use:

1. Increased susceptibility to infection — Apoquel suppresses JAK-dependent immune signalling. Dogs on long-term treatment are more vulnerable to bacterial, fungal, and viral infections. UTIs and ear infections appear in the Common adverse events category in the official SPC.

2. Neoplastic conditions — The VMD SPC advises caution in dogs with pre-existing neoplastic conditions because JAK pathway modulation may reduce immune surveillance. No definitive causal link to cancer has been established in peer-reviewed literature, but lymphoma appears in post-market adverse event data as a rare isolated report.

3. Liver and kidney effects — Apoquel is metabolised in the liver. Long-term use can affect liver enzyme levels and, less commonly, kidney function. Regular blood monitoring is essential.

4. Aggression — Listed in the Common adverse events category in the SPC. Not fully understood mechanistically but reported with sufficient frequency to appear in the official regulatory data.

Full adverse event frequency (UK VMD SPC):

Very Common (more than 1 in 10 dogs): Pyoderma, skin lump, papilloma

Common (1–10 in 100 dogs): Lethargy, lipoma, polydipsia (increased thirst), increased appetite, nausea, vomiting, diarrhoea, anorexia, histiocytoma, fungal skin infection, pododermatitis (inflamed paws), otitis (ear infection), lymphadenopathy (swollen lymph nodes), cystitis (bladder infection), aggression

Rare / Isolated post-market reports: Anaemia, lymphoma, convulsion (seizure)

Blood Monitoring Guide for Dogs on Long-Term Apoquel

If your vet has not outlined a monitoring schedule, it is entirely reasonable to ask for one.

• Complete Blood Count (CBC) — immune suppression can reduce white blood cell count; anaemia is a rare but listed adverse event. Look for low WBC, low RBC, low platelets.
• Liver enzymes (ALT, ALP) — Apoquel is hepatically metabolised. Monitor for elevated ALT or ALP indicating liver stress.
• Kidney function (BUN, Creatinine) — renal effects reported with long-term use. Elevated values warrant veterinary review.
• Serum chemistry (Albumin, Globulin) — protein levels reflect systemic organ and immune function.
• Electrolytes — monitor fluid and kidney balance.
• Urinalysis — UTIs are a Common adverse event. Look for bacteria, white cells, and crystals in urine. Recommended every 6 months.
• Fecal occult blood — rules out GI bleeding, a rare adverse event.
• Thyroid hormones (T4, TSH) — JAK pathway modulation may interact with thyroid signalling in some dogs.

Most vets recommend a full blood panel every 6–12 months. If your dog develops new symptoms — increased thirst, weight changes, lethargy, or new lumps — request an earlier review rather than waiting for a scheduled check.

How Much Does Apoquel Cost in the UK?

Apoquel is available in 3.6mg, 5.4mg, and 16mg strengths. Dosing is weight-based, typically 0.4–0.6mg/kg twice daily for 14 days then once daily for maintenance. Monthly costs in the UK typically range from £60 to £120 depending on your dog's weight and where you purchase.

💡 Cost-saving fact: UK vets are legally required to issue a written prescription for any POM-V medication on request. Purchasing Apoquel via written prescription from a registered online veterinary pharmacy (VetUK, PetDrugs Online, Vet-Medic) is typically 20–40% cheaper than purchasing from your vet's own dispensary. You are entitled to ask for this — it is not an unusual request.

Apoquel vs Cytopoint: Which Anti Itch Medication Is Right for Your Dog?

Both are effective and prescription-only. Both target the IL-31-driven itch pathway — but by different mechanisms, with different risk profiles and practical implications.

Some dogs are prescribed both simultaneously for severe, poorly controlled atopic dermatitis — this is off-label but practised under veterinary supervision with monitoring.

What to Do If Apoquel Stops Working

Do not assume the medication has failed. The most common reasons itch returns while on Apoquel are:

• Secondary skin infection — the most frequent reason. A bacterial or yeast infection generates independent itch that Apoquel does not address. Your vet can identify this with cytology. Antibiotics or antifungals are needed first — Apoquel is not anti-infective.

• Change in allergen exposure — seasonal shifts, new carpets, change in washing powder, or a new food ingredient can introduce allergens that overwhelm control at the current dose.

• Disease progression — atopic dermatitis is progressive. A dog well-controlled for several years may need dose adjustment or a treatment step-up.

• Genuine treatment failure — a proportion of dogs do not respond adequately long-term. Switching to or adding Cytopoint, trialling cyclosporine, or referral to a veterinary dermatologist for allergy testing and immunotherapy are the appropriate next steps.

Alternatives to Apoquel for Dogs

• Cytopoint (lokivetmab) — monthly injection targeting IL-31 only. No broad immune suppression. Preferred for dogs with infection history, neoplasia history, or where owners prefer no daily tablet.

• Cyclosporine (Atopica) — oral immunosuppressant with a different mechanism. Slower onset (4–6 weeks) but well-established long-term. Similar monitoring requirements to Apoquel.

• Short-term prednisolone (steroids) — effective for acute flare management only. Not appropriate long-term due to metabolic and immunological effects.

• Allergen-specific immunotherapy (ASIT) — the only treatment addressing the root cause of environmental allergies. Requires allergy testing and a customised desensitisation programme. Takes 6–12 months for full effect.

• Antihistamines (Piriton, Benadryl) — effective only for histamine-driven reactions such as acute insect sting responses. Largely ineffective for chronic atopic dermatitis.

Why Skin Barrier Repair Matters Alongside Apoquel

Apoquel controls the itch signal — it does not repair the underlying skin barrier defect central to atopic dermatitis. Dogs with atopic dermatitis have compromised skin: ceramide deficiency, elevated transepidermal water loss, and an altered skin microbiome that allows allergens and pathogens to penetrate more easily. Without addressing this, the inflammatory cycle continues at the skin level even when systemic itch signals are suppressed.

Clinical studies in veterinary dermatology consistently show that topical skin barrier support reduces flare frequency and severity in atopic dogs, and may allow lower doses of systemic medication over time.

Our DermaRenew Skin Repair Serum is formulated with Calendula officinalis, Lavandula angustifolia, and Chamomilla recutita — botanical actives with demonstrated anti-inflammatory, antimicrobial, and barrier-supporting properties in peer-reviewed veterinary research. It complements your vet's treatment plan — not replaces it.

Frequently Asked Questions

What is Apoquel used for in dogs?
Apoquel is an anti itch medication for dogs controlling pruritus and inflammation from atopic dermatitis, flea allergy dermatitis, and allergic skin conditions. It inhibits JAK1 and JAK3 enzymes that drive the itch-inflammation cycle.

Does Apoquel cause cancer in dogs?
No definitive causal link has been established. The UK VMD SPC advises caution in dogs with pre-existing neoplastic conditions because JAK modulation may theoretically reduce immune surveillance. Lymphoma appears as a rare isolated post-market report. Discuss with your vet if your dog has a cancer history.

Can Apoquel and Cytopoint be used together?
Yes — some vets prescribe both for dogs with severe poorly controlled atopic dermatitis. Off-label use requiring veterinary supervision and monitoring.

Is Apoquel safe for long-term use?
It can be with regular blood monitoring and periodic risk-benefit review, particularly for dogs with infection history, organ disease, or neoplasia.

How quickly does Apoquel work?
Within 4 hours of the first dose. Most dogs show significant itch reduction within 24 hours.

What is the difference between Apoquel and Piriton?
Apoquel is significantly more effective for most canine itch. Piriton blocks histamine only — but histamine is not the primary itch driver in atopic dermatitis. Apoquel targets the cytokine pathways that actually cause the itch.

Can you skip a day of Apoquel?
Give the missed dose as soon as you remember. Do not double up. Missing one dose occasionally is unlikely to cause harm but may allow symptoms to return briefly.

Why wash hands after touching Apoquel?
Apoquel is classified as hazardous due to its immunomodulatory properties. Wash hands thoroughly after handling, especially if pregnant or immunocompromised.

What to do if Apoquel stops working?
Rule out secondary skin infection first via veterinary cytology. Then review allergen exposure, consider dose adjustment, or discuss switching to or adding Cytopoint. Persistent poor control warrants dermatology referral.

Is Apoquel or Cytopoint better?
Neither is universally better. See the full comparison table above. The right choice depends on your dog's individual clinical picture.

References

1. Zoetis. Apoquel (oclacitinib) Summary of Product Characteristics (UK). VMD Product Information Database.
2. Gadeyne, C., et al. (2014). Efficacy of oclacitinib compared with prednisolone for the control of pruritus in dogs with allergic dermatitis. Veterinary Dermatology, 25(6), 512–e86.
3. Cosgrove, S. B., et al. (2013). Oclacitinib is effective for the control of pruritus and skin lesions in dogs with atopic dermatitis. Veterinary Dermatology, 24(5), 479–e114.
4. Gonzales, A. J., et al. (2014). Oclacitinib is a novel JAK inhibitor with activity against cytokines involved in allergy. Journal of Veterinary Pharmacology and Therapeutics, 37(4), 317–324.
5. Papich, M. G. (2016). Veterinary Drug Handbook. 9th ed. Wiley-Blackwell.
6. UK Veterinary Medicines Directorate. Product Information Database. vmd.defra.gov.uk.

Disclaimer: This article has been written by a UK-registered pharmacist for general informational and educational purposes only. It does not constitute veterinary advice and is not a substitute for professional veterinary consultation, diagnosis, or treatment. Always seek the guidance of a qualified veterinary surgeon regarding any questions about your pet's health, medication, or medical condition. Never disregard professional veterinary advice or delay seeking it because of something you have read in this article. The information reflects peer-reviewed literature and UK veterinary guidance available at the time of writing and is subject to change. FurBabies™ Botanicals and its founder accept no liability for any loss, injury, or damage arising from reliance on this content. Product recommendations relating to FurBabies™ Botanicals are included for informational purposes and should be discussed with your veterinary surgeon before use. This article is intended for a UK audience only.